List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 400 studies with search of: Influenza Type A
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Suspended Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B
Condition: Influenza
Interventions: Device: fluID Rapid Influenza Test;   Device: BinaxNOW® Influenza A & B
2 Enrolling by invitation A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
Condition: Influenza
Intervention: Biological: H1N1 influenza A Vaccine (Split virion), Inactivated
3 Not yet recruiting Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
Condition: Influenza
Intervention: Biological: inactivated influenza A/H5N1 vaccine
4 Recruiting Antiviral Therapy for Influenza A H1N1
Condition: Influenza A Virus Infection
Intervention:
5 Enrolling by invitation Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
Condition: Influenza
Interventions: Biological: Pandemic influenza A/H1N1 vaccine;   Biological: Seasonal trivalent vaccine
6 Completed Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
Condition: Influenza
Interventions: Biological: Influenza A/H7N7 Vaccine;   Drug: Placebo
7 Recruiting Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Influenza A(H1N1) vaccines
8 Recruiting A Randomized Open Label Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza A H1N1 Immune Plasma for the Treatment of Influenza A H1N1 2009
Conditions: H1N1 Influenza;   Swine Flu
Intervention: Drug: H1N1 Plasma
9 Not yet recruiting Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
Condition: Influenza A
Intervention: Biological: Influenza A vaccine
10 Recruiting Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangding, Mainland China
Condition: Influenza Type A or B
Intervention: Procedure: Nasopharyngeal Swab
11 Completed H5 Vaccine Alone or With Adjuvant in Healthy Adults
Condition: Influenza
Interventions: Drug: Aluminum hydroxide;   Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur pre-adsorbed)
12 Completed H9 Priming Study in Healthy Adults
Condition: Influenza
Intervention: Biological: Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine
13 Completed A Clinical Trial With Influenza A/H1N1 Vaccines
Condition: Influenza
Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose;   Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose;   Biological: placebo control
14 Completed Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
Condition: Influenza
Interventions: Biological: Influenza A/H9N2 vaccine;   Drug: MF59 adjuvant
15 Completed
Has Results 		Higher Dose Intradermal H5 Vaccine
Condition: Influenza
Interventions: Biological: Inactivated Influenza A Vaccine A/H5N1;   Drug: Placebo (ID);   Drug: Placebo (IM)
16 Completed A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
Condition: Influenza
Interventions: Biological: Influenza A/H5N1 Vaccine;   Drug: Placebo
17 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
18 Active, not recruiting Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
19 Recruiting Novel Influenza A (H1N1) Surveillance Registry
Conditions: Novel Influenza A;   H1N1;   Influenza
Intervention:
20 Active, not recruiting Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
Condition: Influenza
Intervention: Biological: Inactivated Influenza A Vaccine A/H5N1 (sanofi pasteur)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services